Cost‐effectiveness analysis of emicizumab prophylaxis in patients with haemophilia A in India
Tulika Seth(Manipal Academy of Higher Education), Tuphan Kanti Dolai(Nil Ratan Sircar Medical College and Hospital), Chandrakala Shanmukhaiah, M. Joseph John(The University of Texas Health Science Center at Houston), Prantar Chakrabarti(Medical College and Hospital, Kolkata), Nita Radhakrishnan
Cited by 17
Related Papers
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
Platelet activation determines the severity of thrombocytopenia in dengue infection
|Scientific Reports|2017|198
Autologous stem cell transplantation in refractory Asherman′s syndrome: A novel cell based therapy
|Journal of Human Reproductive Sciences|2014|184
Environmental and occupational determinants of lung cancer
|Translational Lung Cancer Research|2019|171
Recommendations for screening and early detection of common cancers in India
|The Lancet Oncology|2015|125